GOODNESS GROWTH HLDGS INC - GDNSF STOCK NEWS

Goodness Growth Holdings (GDNSF) and Vireo Health have partnered with Green Flower to establish the GF Institute, aiming to enhance the cannabis industry through standardized education and professional credentials. This initiative addresses the industry's rapid growth by offering three initial credentials: Dispensary Associate, Cultivation Technician, and Manufacturing Agent, each comprising 15 hours of online training. Successful participants gain GFI membership, which includes access to ongoing education and networking opportunities. This collaboration seeks to improve workforce development and operational transparency in the regulated cannabis market.

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) announced that its subsidiary, Resurgent Biosciences, is recruiting 100 participants for an anonymous survey. The study aims to explore the effects of entheogens and psychedelics used for therapeutic and spiritual purposes. This IRB-approved research shifts focus from synthetic psychedelics to natural substances. By gathering self-reported data from users of entheogen therapy centers, Resurgent hopes to enhance understanding and development of psychedelic therapies. The study is in partnership with Flor da Jurema in Brazil.

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) announced it will host Minnesota's first cannabis expungement clinic on September 11, 2021, at its Green Goods® center in Minneapolis. This free event aims to assist Minnesotans with simple, non-violent cannabis convictions in clearing their records, thereby improving employment opportunities, especially for people of color. Legal support will be provided by local attorneys and law students. Health protocols will be in place due to COVID-19, and registration is required. Goodness Growth also plans additional clinics in Maryland and New York.

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) announced that its subsidiary, Resurgent Biosciences, has received a Notice of Allowance from the USPTO for a patent on "Cannabis Based Moist Snuff." This patent protects the delivery format and production process for a new cannabis product. The moist snuff aims to tap into the multi-billion-dollar tobacco market, targeting both retail and wholesale sales. The product promises quicker bioavailability compared to edibles while being customizable in cannabinoid profiles. This innovation aligns with the company's strategy to offer safer cannabis alternatives.

Goodness Growth Holdings, Inc. (GDNSF) announced that its Minnesota subsidiary, Vireo Health, will operate a Green Goods® educational booth at the Minnesota State Fair. Vireo MN is the largest medical cannabis company in Minnesota, with eight cannabis patient centers and 67,000 square feet of cultivation. The booth will provide information about medical cannabis along with up to $200 in discounts for new patients. This initiative aims to educate the community about cannabis benefits and enhance patient engagement in Minnesota's medical cannabis program.

Goodness Growth Holdings, Inc. (CSE: GDNS; OTCQX: GDNSF) has opened two new Green Goods® cannabis dispensaries in New Mexico, located in Albuquerque and Las Cruces. These strategic locations are part of the company's preparation for the state's adult-use cannabis program set to launch in spring 2022. The dispensaries will create up to 30 jobs and feature a wide range of cannabis products. Additionally, the company's cultivation capabilities have been expanded significantly, increasing production capacity by up to eight times, supporting future demand.

Goodness Growth Holdings reported its second-quarter financial results for 2021, revealing a total revenue of $14.2 million, a 16.5% year-over-year increase. Excluding former subsidiaries, revenue rose 44.5%. Gross profit stood at $6.9 million with a margin of 48.6%, up from 29.4% in Q2 2020. Despite increased SG&A expenses of $8.3 million, net loss decreased to $5.5 million from $16.1 million the previous year. Expansion efforts in New Mexico and Arizona are expected to boost revenue in the latter half of 2021.

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) has appointed Josh Rosen to its Board of Directors, expanding its board to seven members. Rosen, a Managing Partner at Bengal Capital and former CEO of 4Front Ventures, brings significant cannabis industry experience, including strategic transformations and successful acquisitions. Chairman Kyle Kingsley expressed optimism about Rosen's contributions during a critical growth phase as the company transitions to adult use markets. Goodness Growth operates in eight markets with 18 dispensaries, focusing on scientific innovation and plant-based medicines.

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) will report its financial results for the second quarter ended June 30, 2021, on August 13, 2021, before market opening. A conference call and webcast will occur the same day at 8:00 a.m. ET. Interested parties can register to attend the call via the provided link. Goodness Growth, a physician-led cannabis company, is focused on developing plant-based medicines through its subsidiaries, including Vireo Health. The company operates in eight markets and runs 18 dispensaries across the U.S.